ViiV Starts Phase III With Two-Drug HIV Regimen In Naïve Patients
Executive Summary
ViiV Healthcare begins a Phase III program for a two-drug regimen for adults with HIV who are treatment naïve, however, clinical data proving both long-term safety and efficacy will be crucial for commercial success.